Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$26.74 - $40.81 $387,730 - $591,745
14,500 New
14,500 $387,000
Q3 2022

Nov 14, 2022

BUY
$37.92 - $63.74 $182,016 - $305,952
4,800 Added 36.92%
17,800 $679,000
Q2 2022

Aug 15, 2022

BUY
$47.98 - $62.75 $345,456 - $451,800
7,200 Added 124.14%
13,000 $709,000
Q1 2022

May 16, 2022

BUY
$49.85 - $96.11 $289,130 - $557,438
5,800 New
5,800 $362,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.